SARS-CoV-2's Wide-Ranging Effects on the Body
The Scientist Magazine,
Researchers’ painstaking examinations have begun to reveal how the virus wreaks havoc in multiple organs and tissues.
Researchers’ painstaking examinations have begun to reveal how the virus wreaks havoc in multiple organs and tissues.
A large proportion of people with COVID-19, particularly severe COVID-19, develop acute kidney injury (AKI).
La pandemia originada por el coronavirus SARS-CoV2 en Wuhan (China) está teniendo una dispersión muy alta.
New research has identified a possible mechanism for blood clotting issues in some COVID-19 patients.
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
A new meta-analysis suggests that severe acute kidney injury that develops in hospitalized COVID-19 patients is significantly…
アストラゼネカ株式会社 重度の合併症および臓器不全によるリスクを低減するフォシーガの可能性を検討 本資料はアストラゼネカ英国本社が2020年4月23日に発信したプレスリリースを日本語に翻訳し、みなさまのご参考に提供するものです。本資料の正式言語は英語であり…
[アストラゼネカ株式会社] 重度の合併症および臓器不全によるリスクを低減するフォシーガの可能性を検討 本資料はアストラゼネカ英国本社が2020年4月23日に発信したプレスリリースを日本語に翻訳し、みなさまのご参考に提供するものです。本資料の正式言語は英語であ…
本資料はアストラゼネカ英国本社が2020年4月23日に発信したプレスリリースを日本語に翻訳し、みなさまのご参考に提供するものです。本資料の正式言語は英語であり、その内容・解釈については英語が優先します。 アストラゼネカ(本社:英国ケンブリッジ、最高経営責任者…
Trial will assess the potential of Farxiga in reducing the risk of serious complications and organ failure AstraZeneca and…
New studies characterize COVID-19 risk factors and outcomes and chronicle how healthcare providers and facilities are dealing…
After the respiratory consequences of COVID-19 and resulting ventilator shortages, acute kidney injury is emerging as the next…
Acute and chronic kidney disease is strongly associated with severity of disease and fatal outcomes in COVID-19 patients.
NEW YORK, April 20, 2020 /PRNewswire/ -- (LSE: RENX), the AIM-traded developer of clinical grade artificial intelligence in…
/PRNewswire/ -- Renalytix AI plc (LSE: RENX), the AIM-traded developer of clinical grade artificial intelligence in vitro…
NEW YORK, April 20, 2020 /PRNewswire/ -- Renalytix AI plc (LSE: RENX), the AIM-traded developer of clinical grade artificial…
NEW YORK, April 20, 2020 /PRNewswire/ -- Renalytix AI plc (LSE: RENX), the AIM-traded developer of clinical grade artificial…
/PRNewswire/ -- (LSE: RENX), the AIM-traded developer of clinical grade artificial intelligence in vitro diagnostics for kidney…
KidneyIntelX™ to Predict Major Adverse Kidney Events in COVID-19 Patients PR Newswire NEW YORK, April 20, 2020 NEW YORK, April…
/PRNewswire/ -- Renalytix AI plc (LSE: RENX), the AIM-traded developer of clinical grade artificial intelligence in vitro…
/PRNewswire/ -- Renalytix AI plc (LSE: RENX), the AIM-traded developer of clinical grade artificial intelligence in vitro…
Latest MedicineNet News APRIL 10, 2020 -- As rates of new cases of COVID-19 show some encouraging signs of slowing in the…
The Story So Far in China; AKI Common in Those With COVID-19 Bruchfeld spoke about a prospective single-center study of 701…
As rates of new cases of COVID-19 show some encouraging signs of slowing in the hardest-hit countries of Spain and Italy…